Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 10;9(4):793.
doi: 10.3390/microorganisms9040793.

SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs

Affiliations
Review

SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs

Alessio Danilo Inchingolo et al. Microorganisms. .

Abstract

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which is believed to have originated in China towards the end of November 2019, has now spread across the globe, causing a pandemic in 192 countries. The World Health Organization has called it the SARS-CoV-2 pandemic. Rapid dissemination of the virus occurs mainly through the saliva (Flügge's droplets) and aerosol, together with nasal and lachrymal passages. The literature associated with the recent advancement in terms of rapid diagnostics and SARS-CoV-2 vaccines has thoroughly studied the role of ACE2 receptors and Furin, as well as viral agent access into the host cell and its significant persistence at the level of the oral mucosa, which represents the main access to the virus. The purpose of this review was to underline the processes of SARS-CoV-2 infection mechanisms and novel breakthroughs in diagnostics and vaccines. Different technologies, such as the RT-PCR molecular test and the antigenic test, have been developed to identify subjects affected by the SARS-CoV-2 in order to improve the tracking of infection geographical diffusion. Novel rapid and highly sensitive diagnostic tests has been proposed for the detection of SARS-CoV-2 to improve the screening capability of suspected contagions. The strengthening of the vaccination campaign represents the most effective means to combat the SARS-CoV-2 infection and prevent severe manifestations of the virus-different classes of vaccines have been developed for this purpose. Further attention on the novel SARS-CoV-2 variant is necessary in order to verify the protection efficacy and virulence reduction of the infective agent in the recent vaccine campaign.

Keywords: ACE2; Cytokine Storm Syndrome (CSS); SARS-CoV-2 (COVID-19 pandemic); TMPRSS2; furin; microbiome; oral mucosa (salivary glands); vaccines.

PubMed Disclaimer

Conflict of interest statement

The co-authors Angelo Michele Inchingolo, Andrea Ballini, Francesco Inchingolo, and Gianna Dipalma were involved in multicentred research at the Phan Chau Trinh University in Vietnam and the University of Bari Aldo Moro in Italy to develop diagnostic procedures for multiple detection of pandemic Coronaviridae family viruses. Patent number (s): 102020000011701 (Italy), EP20197796.4 (Europe), 17/034,407 (USA), PT20202942-FF-P-HK (Hong Kong). The other authors declare no conflict of interest in the present investigation.

Figures

Figure 1
Figure 1
SARS-CoV-2. Spike Glycoprotein. RNA and N Protein, Envelope, Protein M, Hemagglutinin-esterase dimer (HE). Figure designed by Giovanna Dipalma.
Figure 2
Figure 2
Mechanism of direct and indirect diffusion of the virus Sars-CoV-2 through droplets and aerosol; figure designed by Giovanna Dipalma.
Figure 3
Figure 3
A rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronavirus family members SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV: A translational research and cooperation between the Phan Chau Trinh Univ. in Vietnam and Univ of Bari “A. Moro”. June 2020. ERMPS 2020; 24: 5183–5201, doi:10.26355/eurrev_202006_21713.
Figure 4
Figure 4
SARS-CoV-2 Binding Receptors.
Figure 5
Figure 5
Summary of the type, storage administration, and efficacy characteristics of the Pfizer Vaccine.
Figure 6
Figure 6
Summary of the type, storage administration, and efficacy characteristics of the Moderna Vaccine.
Figure 7
Figure 7
Summary of the type, storage administration, and efficacy characteristics of the AstraZeneca Vaccine.
Figure 8
Figure 8
Summary of the type, storage administration, and efficacy characteristics of the Janssen vaccine.
Figure 9
Figure 9
Summary of the type, storage administration, and efficacy characteristics of the Sputnik vaccine.
Figure 10
Figure 10
Summary of the type, storage administration, and efficacy characteristics of Coronavac vaccine.

References

    1. COVID-19 Map. [(accessed on 4 January 2021)]; Available online: https://coronavirus.jhu.edu/map.html.
    1. Santacroce L., Bottalico L., Charitos I.A. The impact of COVID-19 on Italy: A lesson for the future. Int. J. Occup. Environ. Med. 2020;11:151–152. doi: 10.34172/ijoem.2020.1984. - DOI - PMC - PubMed
    1. Spagnuolo G., De Vito D., Rengo S., Tatullo M. COVID-19 outbreak: An overview on dentistry. Int. J. Environ. Res. Public Health. 2020;17:2094. doi: 10.3390/ijerph17062094. - DOI - PMC - PubMed
    1. Balzanelli M.G., Distratis P., Aityan S.K., Amatulli F., Catucci O., Cefalo A., De Michele A., Dipalma G., Inchingolo F., Lazzaro R., et al. An Alternative “Trojan Horse” Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology. Endocr. Metab. Immune Disord. Drug Targets. 2021;21:1. doi: 10.2174/1871530321666210127141945. - DOI - PubMed
    1. Balzanelli M.G., Distratis P., Catucci O., Amatulli F., Cefalo A., Lazzaro R., Aityan K.S., Dalagni G., Nico A., de Michele A., et al. Clinical and diagnostic findings in COVID-19 patients: An original research from SG Moscati Hospital in Taranto Italy. J. Biol. Regul. Homeost. Agents. 2021;35:171–183. - PubMed